These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
501 related items for PubMed ID: 34737009
1. Efficacy of Modified Huangqi Chifeng decoction in alleviating renal fibrosis in rats with IgA nephropathy by inhibiting the TGF-β1/Smad3 signaling pathway through exosome regulation. Zhao M, Yang B, Li L, Si Y, Chang M, Ma S, Li R, Wang Y, Zhang Y. J Ethnopharmacol; 2022 Mar 01; 285():114795. PubMed ID: 34737009 [Abstract] [Full Text] [Related]
2. Protective effect of modified Huangqi Chifeng decoction on immunoglobulin A nephropathy through toll-like receptor 4/myeloid differentiation factor 88/nuclear factor-kappa B signaling pathway. Liusheng LI, Mingming Z, Meiying C, Yuan SI, Jinning Z, Bin Y, Yu Z. J Tradit Chin Med; 2024 Apr 01; 44(2):324-333. PubMed ID: 38504538 [Abstract] [Full Text] [Related]
3. [Anti-renal Fibrosis Mechanism of Modified Huangqi Chifeng Decoction Based on TGF-p1/Smad Signal Pathway]. Gao YH, Zhang Y, Li P, Liu HX, Li S, Yu ZK. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Dec 01; 36(12):1486-1490. PubMed ID: 30650295 [Abstract] [Full Text] [Related]
4. Effects of modified Huangqi Chifeng decoction on the IL-17 signaling pathway in an IgA nephropathy rat model. Ma S, Yang B, Zhao M, Li P, Fan J, Chang M, Pan Z, Zhang Z, Xue S, Zhang Y. J Ethnopharmacol; 2023 May 10; 307():116220. PubMed ID: 36750149 [Abstract] [Full Text] [Related]
5. [Modified Fangji Huangqi Decoction alleviates renal interstitial fibrosis by inhibiting TGF-β1/Smad/Snail signaling pathway during epithelial-mesenchymal transition]. Deng YW, Jin L, Chen DP. Zhongguo Zhong Yao Za Zhi; 2024 Jun 10; 49(11):3012-3020. PubMed ID: 39041161 [Abstract] [Full Text] [Related]
6. Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-β1/Smad3 Signaling Pathway in Hyperuricemic Nephrology Rats. Liu P, Wang C, Wang Y, Zhang H, Liu B, Qiu X. Biomed Res Int; 2021 Jun 10; 2021():2793823. PubMed ID: 34938805 [Abstract] [Full Text] [Related]
7. Modified Huangqi Chifeng Decoction Attenuates Proteinuria by Reducing Podocyte Injury in a Rat Model of Immunoglobulin a Nephropathy. Chang M, Yang B, Li L, Si Y, Zhao M, Hao W, Zhao J, Zhang Y. Front Pharmacol; 2021 Jun 10; 12():714584. PubMed ID: 34381367 [Abstract] [Full Text] [Related]
8. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway. Gu LY, Yun-Sun, Tang HT, Xu ZX. J Ethnopharmacol; 2021 Dec 05; 281():113548. PubMed ID: 33152427 [Abstract] [Full Text] [Related]
9. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction. Xianyuan L, Wei Z, Yaqian D, Dan Z, Xueli T, Zhanglu D, Guanyi L, Lan T, Menghua L. Phytomedicine; 2019 Feb 05; 53():274-285. PubMed ID: 30668407 [Abstract] [Full Text] [Related]
10. Ameliorative effects of Modified Huangqi Chifeng decoction on podocyte injury via autophagy mediated by PI3K/AKT/mTOR and AMPK/mTOR pathways. Zhao M, Yin Y, Yang B, Chang M, Ma S, Shi X, Li Q, Li P, Zhang Y. J Ethnopharmacol; 2024 Mar 01; 321():117520. PubMed ID: 38042389 [Abstract] [Full Text] [Related]
11. Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway. Pei S, Li Y. Clinics (Sao Paulo); 2021 Mar 01; 76():e2904. PubMed ID: 34909911 [Abstract] [Full Text] [Related]
12. [Effects of Shenqi Jiedu Decoction on expressions of transforming growth factor-beta1, smad2 and smad3 in renal tissues of rats with chronic renal failure induced by adenine]. Li TT, Si GM, Chen FC. Zhong Xi Yi Jie He Xue Bao; 2010 Mar 01; 8(3):263-8. PubMed ID: 20226149 [Abstract] [Full Text] [Related]
13. Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling. Zhao TT, Zhang HJ, Lu XG, Huang XR, Zhang WK, Wang H, Lan HY, Li P. PLoS One; 2014 Mar 01; 9(3):e90807. PubMed ID: 24646636 [Abstract] [Full Text] [Related]
14. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation. Zhou Y, Tong X, Ren S, Wang X, Chen J, Mu Y, Sun M, Chen G, Zhang H, Liu P. J Ethnopharmacol; 2016 Aug 22; 190():83-90. PubMed ID: 27282665 [Abstract] [Full Text] [Related]
15. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro. Zhao J, Wang L, Cao AL, Jiang MQ, Chen X, Wang Y, Wang YM, Wang H, Zhang XM, Peng W. Cell Physiol Biochem; 2016 Aug 22; 38(5):1761-74. PubMed ID: 27161221 [Abstract] [Full Text] [Related]
16. JinSanE decoction, a chinese herbal medicine, inhibits expression of TGF-beta1/Smads in experimental hepatic fibrosis in rats. Song SL, Gong ZJ, Huang YQ, Zhang QR, Huang TX. Am J Chin Med; 2006 Aug 22; 34(6):1047-61. PubMed ID: 17163593 [Abstract] [Full Text] [Related]
17. Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway. Wu T, Chen JM, Xiao TG, Shu XB, Xu HC, Yang LL, Xing LJ, Zheng PY, Ji G. World J Gastroenterol; 2016 May 21; 22(19):4695-706. PubMed ID: 27217701 [Abstract] [Full Text] [Related]
18. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy. Lang H, Dai C. Arch Med Res; 2016 Feb 21; 47(2):71-7. PubMed ID: 27018336 [Abstract] [Full Text] [Related]
19. miR-136 improves renal fibrosis in diabetic rats by targeting down-regulation of tyrosine kinase SYK and inhibition of TGF-β1/Smad3 signaling pathway. Liu L, Pang X, Shang W, Feng G, Wang Z, Wang J. Ren Fail; 2020 Nov 21; 42(1):513-522. PubMed ID: 32441195 [Abstract] [Full Text] [Related]
20. Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy. Du N, Xu Z, Gao M, Liu P, Sun B, Cao X. Drug Des Devel Ther; 2018 Nov 21; 12():3517-3524. PubMed ID: 30425453 [Abstract] [Full Text] [Related] Page: [Next] [New Search]